Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01)

קרןNational Cancer Institute/NIH
סוגResearch Grants
תאריך אחרון30/09/2020
תאריכים נוספים11/02/2021
פקולטהLife Sciences, Medicine

The purpose of this grant is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or developas delayed posttreatment effects. Basic, translational, and/or clinical research projects are welcome. 



Funding: No fixed limit 

Duration: 5 years 


Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates:  30.8.19, 11.1.120, 30.8.20, 11.1.21, 20.8.21, 11.1.22

Full proposal due dates:  30.9.19, 11.2.20, 30.9.20, 11.2.21, 20.9.21, 11.2.22

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 31/07/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive